# Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

> **NCT04276857** · NA · RECRUITING · sponsor: **University of Saskatchewan** · enrollment: 27 (estimated)

## Conditions studied

- Locally Advanced Pancreatic Cancer
- Irreversible Electroporation

## Interventions

- **DEVICE:** Irreversible electroporation (NanoKnife® )

## Key facts

- **NCT ID:** NCT04276857
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04276857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04276857, "Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04276857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*